Mon, Mar 2, 2015, 10:50 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Pacific Biosciences of California, Inc. Message Board

  • medicalstarl medicalstarl Aug 8, 2013 9:29 AM Flag

    Please Read this about IGXT (MarketCap $30 Mil) 2 Drugs under review by FDA

    IntelGenx (IGXT :$0.60) – Drug Delivery company focused on Oral method with strong pipeline of pharma drugs

    Targets: Near term: $2 – $3 /// Long term: $5+

    6th August, 2013

    New HOT Stock pick: IntelGenx Corp. (IGXT: $0.60)

    IntelGenx has an FDA approved drug (Fortivo XL) on the market and several in pipeline for various indications with multi billion dollar market for some of the other approved drugs on the market for the treatments. Company has many good partnerships in place with companies like PAR Pharma, RedHill BioPharma, Edgemont Pharmaceuticals and others.
    IntelGenx is uniquely positioned to capture a huge marketshare given its large portfolio of patents in Drug Delivery Systems. It has 3 key methods:
    1) VersaTab – Controlled release tablets
    2) VersaFilm – Rapidly disintegrating film
    3) AdVersa – Mucoadhesive tablet

    Company has NO debt and has sufficient cash for near term giving its current burn rate.
    Current capital structure includes:

    Shares outstanding: 58 Million
    Insider Ownership: 22%


6.32+0.02(+0.32%)Mar 2 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.